Subgroup Efficacy Analyses of

LongActing Subcutaneous Lenacapavir in Heavily TreatmentExperienced People With HIV in the Phase 23 CAPELLA Study 1 ICH Study Center Hamburg Germany 2 Orlando Immunology Center Orlando Florida USA

Embed this Presentation

Download Notice

Download Presentation The PPT/PDF document "Subgroup Efficacy Analyses of" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.